{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:51:30Z","timestamp":1785711090852,"version":"3.56.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["2022A0505050048"],"award-info":[{"award-number":["2022A0505050048"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52303181"],"award-info":[{"award-number":["52303181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571532"],"award-info":[{"award-number":["32571532"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472064"],"award-info":[{"award-number":["82472064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017689","name":"Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["8220100484"],"award-info":[{"award-number":["8220100484"]}],"id":[{"id":"10.13039\/501100017689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012369"],"award-info":[{"award-number":["2024A1515012369"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LMS25E030004"],"award-info":[{"award-number":["LMS25E030004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102940","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T11:21:59Z","timestamp":1775388119000},"page":"102940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Osimertinib delivery using 660\u00a0nm-activated polymeric nano-photosensitizer carriers for combined photodynamic and EGFR-targeted therapy of non-small cell lung cancer"],"prefix":"10.1016","volume":"74","author":[{"given":"Fanjun","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102940_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nano.2026.102940_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nano.2026.102940_bb0020","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21147\/j.issn.1000-9604.2024.05.01","article-title":"Non-small cell lung cancer organoids: advances and challenges in current applications","volume":"36","author":"Wu","year":"2024","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.nano.2026.102940_bb0025","first-page":"139","article-title":"Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016","volume":"2","author":"Zheng","year":"2022","journal-title":"J Nat Cancer Cent"},{"key":"10.1016\/j.nano.2026.102940_bb0030","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.nano.2026.102940_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41571-021-00501-4","article-title":"Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancer","volume":"18","author":"Chaft","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0040","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamaoncol.2017.1047","article-title":"Targeted therapy as an alternative to whole-brain radiotherapy in EGFR-mutant or ALK-positive non-small-cell lung cancer with brain metastases","volume":"3","author":"Martinez","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2017.11.019","article-title":"Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy","volume":"52","author":"Osmani","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.nano.2026.102940_bb0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.actbio.2017.12.003","article-title":"An implantable depot capable of in situ generation of micelles to achieve controlled and targeted tumor chemotherapy","volume":"67","author":"Luo","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102940_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/rb\/rbaa019","article-title":"Cell-derived biomimetic nanoparticles as a novel drug delivery system for atherosclerosis: predecessors and perspectives","volume":"7","author":"Yang","year":"2020","journal-title":"Regen Biomater"},{"key":"10.1016\/j.nano.2026.102940_bb0060","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.7150\/thno.116250","article-title":"Metabolic targeting of oxidative phosphorylation enhances chemosensitivity in triple-negative breast cancer via a synergistic nanomedicine","volume":"15","author":"Shen","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2026.102940_bb0065","first-page":"84","article-title":"Patients with uncommon EGFR mutations also benefit from first-line Osimertinib","volume":"21","author":"Romero","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0070","article-title":"A bispecific antibody targeting EGFR and AXL delays resistance to Osimertinib","volume":"5","author":"Simoni-Nieves","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.nano.2026.102940_bb0075","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41467-023-35961-y","article-title":"Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer","volume":"14","author":"Chmielecki","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102940_bb0080","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jtho.2021.06.013","article-title":"Acquired resistance to third-generation EGFR tyrosine kinase inhibitors in patients with de novo EGFR T790M-mutant NSCLC","volume":"16","author":"Park","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0085","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1158\/0008-5472.CAN-20-2435","article-title":"Alterations in the global proteome and phosphoproteome in third generation EGFR TKI resistance reveal drug targets to circumvent resistance","volume":"81","author":"Zhang","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2026.102940_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.nano.2026.102940_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaf054","article-title":"Nanomaterial-assisted pancreatic cancer theranostics","volume":"12","author":"Liu","year":"2025","journal-title":"Regen Biomater"},{"key":"10.1016\/j.nano.2026.102940_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Cancer"},{"key":"10.1016\/j.nano.2026.102940_bb0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1200\/JCO.20.01171","article-title":"Cardiac safety of osimertinib: a review of data","volume":"39","author":"Ewer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0110","article-title":"Exposure response and safety analysis of osimertinib in combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of locally advanced or metastatic NSCLC patients with EGFRm (FLAURA2)","volume":"84","author":"Yang","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2026.102940_bb0115","first-page":"e865","article-title":"Photodynamic therapy applications - a review","volume":"92","author":"Michalak","year":"2023","journal-title":"J Med Sci"},{"key":"10.1016\/j.nano.2026.102940_bb0120","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/app11083626","article-title":"Photodynamic therapy-an up-to-date review","volume":"11","author":"Niculescu","year":"2021","journal-title":"Appl Sci Basel"},{"key":"10.1016\/j.nano.2026.102940_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1572-1000(04)00008-0","article-title":"Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University","volume":"1","author":"Kato","year":"2004","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.nano.2026.102940_bb0130","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.12-2377","article-title":"Executive summary: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Detterbeck","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.nano.2026.102940_bb0135","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","article-title":"NCCN guidelines insights: non\u2013small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines","volume":"17","author":"Ettinger","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.nano.2026.102940_bb0140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2026.102940_bb0145","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1039\/D0CS00173B","article-title":"Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application","volume":"50","author":"Zhao","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2026.102940_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acs.accounts.0c00606","article-title":"Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer","volume":"54","author":"Nguyen","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2026.102940_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900132","article-title":"Photosensitizers for photodynamic therapy","volume":"8","author":"Lan","year":"2019","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.128844","article-title":"Recent advances in the development of near-infrared organic photothermal agents","volume":"417","author":"Li","year":"2021","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nano.2026.102940_bb0165","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1039\/D3CS00227F","article-title":"Near-infrared metal agents assisting precision medicine: from strategic design to bioimaging and therapeutic applications","volume":"52","author":"Li","year":"2023","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2026.102940_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202404587","article-title":"Enzyme-activatable near-infrared hemicyanines as modular scaffolds for in vivo photodynamic therapy","volume":"63","author":"Cheng","year":"2024","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nano.2026.102940_bb0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2023.12.046","article-title":"Polymyxin B-targeted liposomal photosensitizer cures MDR A. baumannii burn infections and accelerates wound healing via M1\/M2 macrophage polarization","volume":"366","author":"Cui","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102940_bb0180","article-title":"Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: a promising strategy targeting solid tumor","volume":"23","author":"Dai","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102940_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007630","article-title":"Recent advances in engineered materials for immunotherapy-involved combination cancer therapy","volume":"33","author":"Liang","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.addr.2019.07.010","article-title":"Nanocarrier-based systems for targeted and site specific therapeutic delivery","volume":"14","author":"Majumder","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102940_bb0195","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1039\/D2CS00247G","article-title":"Bioengineered nanogels for cancer immunotherapy","volume":"51","author":"Ma","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2026.102940_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106059","article-title":"Reversing adenosine-mediated immunosuppression in triplenegative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines","volume":"123","author":"Cheng","year":"2026","journal-title":"eBioMedicine"},{"key":"10.1016\/j.nano.2026.102940_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jccs.202400179","article-title":"Engineered metal nanoparticles for precision drug delivery: pioneering the future of medicine: Mini review","volume":"71","author":"Ullah","year":"2024","journal-title":"J Chin Chem Soc"},{"key":"10.1016\/j.nano.2026.102940_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2023.05.043","article-title":"Overcoming tumor microenvironment obstacles: current approaches for boosting nanodrug delivery","volume":"166","author":"Wang","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102940_bb0220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2016.03.010","article-title":"Poly(lactic acid)-Mass production, processing, industrial applications, and end of life","volume":"107","author":"Castro-Aguirre","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2026.102940_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijbiomac.2018.12.002","article-title":"Poly (lactic acid) blends: processing, properties and applications","volume":"125","author":"Nofar","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102940_bb0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduction Tar Ther"},{"key":"10.1016\/j.nano.2026.102940_bb0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101863","article-title":"On-demand phototoxicity inhibition of sensitizers and H2S-triggered in- situ activation for precise therapy of colon cancer","volume":"50","author":"Wen","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2026.102940_bb0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pdpdt.2012.01.003","article-title":"Optical properties of hematoporphyrin monomethyl ether (HMME), a PDT photosensitizer","volume":"9","author":"Lei","year":"2012","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.nano.2026.102940_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202943","article-title":"F\u00f6rster resonance energy transfer nanobullet for photoacoustic imaging and amplified photothermal-photodynamic therapy of cancer","volume":"12","author":"Tan","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.153602","article-title":"Design of multifunctional theranostic nanoplatforms with glutathione-triggered H2S generation and H2S-activitated multi-modal therapy","volume":"495","author":"Tao","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nano.2026.102940_bb0260","article-title":"pH-driven butterfly effect for cascade-amplifed tumor therapy based on thalidomide coordinated Fe-HMME nanoplatform","volume":"32","author":"Qu","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102940_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202470286","article-title":"A versatile cryomicroneedle patch for traceable photodynamic therapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.nano.2026.102940_bb0270","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.actbio.2021.05.018","article-title":"Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer","volume":"129","author":"Chen","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102940_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-01766-w","article-title":"Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer","volume":"21","author":"Huang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2026.102940_bb0280","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2026.102940_bb0285","article-title":"Micro-nanocarriers based drug delivery technology for blood-brain barrier crossing and brain tumor targeting therapy","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.nano.2026.102940_bb0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7150\/thno.117363","article-title":"Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics","volume":"16","author":"Li","year":"2026","journal-title":"Theranostics"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:24:59Z","timestamp":1785709499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":58,"alternative-id":["S1549963426000419"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102940","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osimertinib delivery using 660\u00a0nm-activated polymeric nano-photosensitizer carriers for combined photodynamic and EGFR-targeted therapy of non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102940"}}